Page 19 - TD-4-3

Tumor Discovery FBXW7 in Leukemia

doi: 10.1111/myc.13759 doi: 10.1159/000541974
24. Cuglievan B, Kantarjian H, Rubnitz JE, et al. Menin 34. Ionete A, Bardas A, Varady Z, Vasilica M, Szegedi O,
inhibitors in pediatric acute leukemia: A comprehensive Coriu D. modified prophylactic donor lymphocyte infusion
review and recommendations to accelerate progress in (DLI) in an adult T cell lymphoma/leukemia (ATLL) patient-
collaboration with adult leukemia and the international modality of relapse prevention. Diseases. 2024;12(9):210.
community. Leukemia. 2024;38(10):2073-2084.
doi: 10.3390/diseases12090210
doi: 10.1038/s41375-024-02368-7
35. Shih AJ, Jun T, Skol AD, et al. Inherited cancer predisposing
25. Cobaleda C, Godley LA, Nichols KE, Wlodarski MW, mutations in patients with therapy-related myeloid
Sanchez-Garcia I. Insights into the molecular mechanisms neoplasms. Br J Haematol. 2023;200(4):489-493.
of genetic predisposition to hematopoietic malignancies: doi: 10.1111/bjh.18543
The importance of gene-environment interactions. Cancer
Discov. 2024;14(3):396-405. 36. Oiwa K, Lee S, Fujita K, Ueda T, Yamauchi T. Clinical
features of clonal cytogenetic abnormalities in Philadelphia-
doi: 10.1158/2159-8290.CD-23-1091
negative cells developed during tyrosine kinase inhibitor
26. He H, Li J, Li W, et al. Clinical features and long-term treatment. Intern Med. 2024;63(5):729-732.
outcomes of pediatric patients with de novo acute doi: 10.2169/internalmedicine.2182-23
myeloid leukemia in China with or without specific gene
abnormalities: A cohort study of patients treated with BCH- 37. Park SE, Lee JK, Kang HJ, Hong YJ, Oh AC, Kim H. A rare
AML 2005. Hematology. 2024;29(1):2406596. case of X-linked four-way Philadelphia chromosome
translocation with therapeutic challenges and clonal
doi: 10.1080/16078454.2024.2406596
evolution. Clin Lab. 2024;70(9).
27. Bastos Silveira B, Di Carvalho Melo L, Amorim Dos
Santos J, et al. Oral manifestations in pediatric patients with doi: 10.7754/Clin.Lab.2024.240323
leukemia: A systematic review and meta-analysis. J Am Dent 38. Yang K, Fu K, Zhang H, et al. PBA2, a novel inhibitor of
Assoc. 2024;155(10):858-870.e30. the beta-catenin/CBP pathway, eradicates chronic myeloid
leukemia including BCR-ABL T315I mutation. Mol Cancer.
doi: 10.1016/j.adaj.2024.07.014
2024;23(1):209.
28. Cobaleda C, Vicente-Duenas C, Nichols KE, Sanchez-
Garcia I. Childhood B cell leukemia: Intercepting the paths doi: 10.1186/s12943-024-02129-1
to progression. Bioessays. 2024;46(9):e2400033. 39. Liu Y, Jang H, Zhang M, Tsai CJ, Maloney R, Nussinov R. The
structural basis of BCR-ABL recruitment of GRB2 in chronic
doi: 10.1002/bies.202400033
myelogenous leukemia. Biophys J. 2022;121(12):2251-2265.
29. Robak T, Pula A, Braun M, Robak E. Extramedullary
and extranodal manifestations in chronic lymphocytic doi: 10.1016/j.bpj.2022.05.030
leukemia - an update. Ann Hematol. 2024;103(9):3369-3383. 40. Al-Rawashde FA, Al-Wajeeh AS, Vishkaei MN, et al.
Thymoquinone inhibits JAK/STAT and PI3K/Akt/mTOR
doi: 10.1007/s00277-024-05854-1
signaling pathways in MV4-11 and K562 myeloid leukemia
30. Sumbly V, Landry I, Sneed C, et al. Leukemic stem cells cells. Pharmaceuticals (Basel). 2022;15(9):1123.
and advances in hematopoietic stem cell transplantation for
acute myeloid leukemia: A narrative review of clinical trials. doi: 10.3390/ph15091123
Stem Cell Investig. 2022;9:10. 41. Shires KL, Rust AJ, Harryparsad R, Coburn JA, Gopie RE.
JAK2/STAT5 pathway mutation frequencies in South
doi: 10.21037/sci-2022-044
African BCR/ABL negative MPN patients. Hematol Oncol
31. Schneider K, Zelley K, Nichols KE, Schwartz Levine A, Stem Cell Ther. 2023;16(3):291-302.
Garber J. Li-Fraumeni syndrome. In: Adam MP, Feldman J,
Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. doi: 10.56875/2589-0646.1064
GeneReviews (R). Seattle (WA): University of Washington; 42. Hegde PS, Andrew G, Gui G, et al. Measurable residual
1993. FLT3 tyrosine kinase domain mutations before allogeneic
transplant for acute myeloid leukemia. Bone Marrow
32. Bhandari J, Thada PK, Killeen RB, Puckett Y. Fanconi
anemia. In: StatPearls. Treasure Island, FL: StatPearls Transplant. 2025;60(2):175-177.
Publishing; 2024. doi: 10.1038/s41409-024-02444-7
33. Barone PD, Tam W, Geyer JT, Leonard JP, Phillips A, 43. Gener-Ricos G, Bataller A, Rodriguez-Sevilla JJ, et al.
Ouseph MM. Nodal T-cell lymphoma transdifferentiated NPM1-mutated myeloid neoplasms are a unique entity
from mantle cell lymphoma with Epstein-Barr virus not defined by bone marrow blast percentage. Cancer.
infection. Pathobiology. 2024;92:1-16. 2024;130(20):3452-3462.

Volume 4 Issue 3 (2025) 11 doi: 10.36922/TD025150027